Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYHX1901 tablets in non-segmental vitiligo (Phase II, randomized, double-blind, placebo-controlled)
CTR20241075Phase 2Active
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SYHX-1901 in Vitiligo, sponsored by CSPC Ouyi Pharmaceutical. Started Jun 2024; status: active.
02
Drugs
SYHX-1901
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20241075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241075.